 |
|
|
|
 |
|
|
 Contact |  Print version |  PDF version |  Recommend company
|
Voltaireweg 4B
14469 Potsdam
Germany
|
|
Portrait
Signature Diagnostics is dedicated to the discovery, validation and commercial development of novel diagnostic products that predict outcome and drug response in patients with colorectal cancer (CRC), non-small cell lung cancer (NSCLC) and ovarian cancer. Signature believes that patient selection and stratification based on molecular gene signatures will soon become an important component of routine cancer treatment. Signature sponsors and executes large prospective multicentre trials in CRC and NSCLC involving several thousand of patients according to ICH standards. Signature aims to improve the quality of decision making in cancer treatment and patient care.
Industrial Sectors
Additional information
Signature Diagnostics AG
Potsdam, Germany
News
|
|
|
|
|
|
Top
